Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

Código QR

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

Yan-rong Jiang,1,2 Zhen-hai Zhang,1 Qi-yuan Liu,1,2 Shao-ying Hu,1,2 Xiao-yun Chen,1,2 Xiao-bin Jia11Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, People’s Republic of China; 2College of Pharmacy, Nan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiang YR, Zhang ZH, Liu QY, Hu SY, Chen XY, Jia XB
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/71bed2bb7ae44a4389056d2ed479f292
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PEI-PEG-Coated Mesoporous Silica Nanoparticles Enhance the Antitumor Activity of Tanshinone IIA and Serve as a Gene Transfer Vector
por: Yinxing Zhu, et al.
Publicado: (2021)

Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro
por: Qin F, et al.
Publicado: (2015)

Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion
por: Ding SM, et al.
Publicado: (2014)

Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
por: Chenhui Zhong, et al.
Publicado: (2021)

PREPARATION AND CHARACTERIZATION OF SOLID DISPERSIONS OF CARVEDILOL WITH POLOXAMER 188
por: SHARMA,ANSHU, et al.
Publicado: (2013)

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
por: Huayuan Liu, et al.
Publicado: (2021)

Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats.
por: Yanlin Chen, et al.
Publicado: (2012)

Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer
por: Wei Zou, et al.
Publicado: (2021)

A novel drug&ndash;phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo
por: Xia HJ, et al.
Publicado: (2013)

Tanshinone IIA Promotes M2 Microglia by ERβ/IL-10 Pathway and Attenuates Neuronal Loss in Mouse TBI Model
por: Chen M, et al.
Publicado: (2020)

SYNTHESIS AND CHARACTERIZATION OF POLYPROPYLENE-SILICA, ALUMINA AND TITANIA NANOPARTICLES, PREPARED BY MELTING
por: ORELLANA,F, et al.
Publicado: (2014)

In vivo toxicologic study of larger silica nanoparticles in mice
por: Chan WT, et al.
Publicado: (2017)

Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
por: Zhang S, et al.
Publicado: (2018)

Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
por: Omwoyo WN, et al.
Publicado: (2014)

Preparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: in vivo and in vitro evaluations
por: Jin X, et al.
Publicado: (2012)

Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hufang Zhou, et al.
Publicado: (2021)

Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process
por: Kim MS, et al.
Publicado: (2011)

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil
por: Shi F, et al.
Publicado: (2012)

Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial
por: Siming Li, et al.
Publicado: (2017)

Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
por: Zaida Urb&aacute;n-Morl&aacute;n, et al.
Publicado: (2010)

Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients
por: Ivanova MV, et al.
Publicado: (2012)

Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method
por: Yang G, et al.
Publicado: (2020)

Enzyme-Functionalized Mesoporous Silica Nanoparticles to Target Staphylococcus aureus and Disperse Biofilms
por: Devlin H, et al.
Publicado: (2021)

Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies
por: Jin X, et al.
Publicado: (2013)

Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations
por: Hu XB, et al.
Publicado: (2019)

Current investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitations
por: Kwon JY, et al.
Publicado: (2014)

Preparation and in vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR
por: Sun HY, et al.
Publicado: (2014)

Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer
por: Chen L, et al.
Publicado: (2018)

Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study
por: Shrestha SC, et al.
Publicado: (2021)

Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation
por: Yang KY, et al.
Publicado: (2013)

Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin
por: Zhang KC, et al.
Publicado: (2013)

Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
por: Xue M, et al.
Publicado: (2013)

Silica nanoparticles trigger hepatic lipid-metabolism disorder in vivo and in vitro
por: Duan J, et al.
Publicado: (2018)

Heat-regulating polylactic acid/silica aerogel composite fabric: Preparation and characterization
por: Chin-San Wu, et al.
Publicado: (2022)

Toxicity of colloidal silica nanoparticles administered orally for 90 days in rats
por: Kim YR, et al.
Publicado: (2014)

Preparation of a magnetic polystyrene nanocomposite for dispersive solid-phase extraction of copper ions in environmental samples
por: Ali Mehdinia, et al.
Publicado: (2020)

Compression of amorphous solid dispersions prepared by hot-melt extrusion, spray drying and vacuum drum drying
por: Barbara V. Schönfeld, et al.
Publicado: (2021)

Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells
por: Wu C, et al.
Publicado: (2018)

Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats
por: Anwer MK, et al.
Publicado: (2019)

Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
por: Zhang L, et al.
Publicado: (2013)